OPKO HEALTH, INC. (OPK) Corporate Subsidiaries
OPKO HEALTH, INC. (OPK) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OPK
CIK: 944809
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerBrent Smith
Audit LocationMiami, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-14 | 8-K | 0001193125-26-422877 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-09-30 | 8-K | 0001193125-26-412284 | View SEC Doc Filr Page |
| 10-Q/A | 2026-08-28 | 2026-06-30 | 10-Q/A | 0001193125-26-374509 | View SEC Doc Filr Page |
| 10-Q/A | 2026-08-28 | 2026-03-31 | 10-Q/A | 0001193125-26-374421 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-13 | 8-K | 0001193125-26-352370 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-07 | — | SCHEDULE 13D Filing | 0000944809-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | 4 | 0001193125-26-321055 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | 4 | 0001193125-26-321041 | View SEC Doc Filr Page |
| 10-Q | 2026-07-27 | 2026-06-30 | 10-Q | 0001193125-26-318090 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | 8-K | 0001193125-26-318069 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-01 | — | SCHEDULE 13D/A Filing | 0000898860-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277749 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277747 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277744 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277740 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277734 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277731 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | 8-K | 0001193125-26-275818 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-15 | — | DEFA14A | 0001193125-26-227011 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-197155 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001193125-26-197143 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001193125-26-197120 | View SEC Doc Filr Page |
| 10-Q | 2026-04-28 | 2026-03-31 | 10-Q | 0001193125-26-187007 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-28 | 8-K | 0001193125-26-186939 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-20 | 4 | 0001193125-26-117703 | View SEC Doc Filr Page |